119 filings
Page 6 of 6
8-K
6eq fuj6daca
23 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ov1iw shbx
31 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
nz2atfvkrdnede2
3 May 16
Departure of Directors or Certain Officers
12:00am
8-K
sgnzkyaq
16 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
htddf5
24 Feb 16
Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am
8-K
esuhh4wx
13 Jan 16
Other Events
12:00am
8-K
w33 8jyj3gjnq6q23in
7 Jan 16
Sage Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
n69g 8mhhfyp0ywmg
16 Dec 15
SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547
12:00am
8-K
3v94gx6
5 Nov 15
SAGE Announces Third Quarter 2015 Financial Results and Recent
12:00am
8-K
g5j8zr4y2d2
6 Oct 15
SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217
12:00am
8-K
ewoj0wr7m16 4xe
12 Aug 15
SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
12:00am
8-K
vyzmzz
3 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
29eye 5lavji3m
14 May 15
SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results
12:00am
8-K
il6arwk ur3dxe
27 Feb 15
SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
2hez3fhj263i
9 Jan 15
SAGE Therapeutics Reports Updated Data from Ongoing Clinical Trial and Emergency
12:00am
8-K
zb11oeq 3d4yi
12 Nov 14
SAGE Therapeutics Reports Third Quarter 2014 Results
12:00am
8-K
wz5jfzmq
16 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
w3jmqgzz
14 Aug 14
SAGE Therapeutics Reports Second Quarter 2014 Financial Results
12:00am
8-K
yr3oi491 6z
25 Jul 14
Amendments to Articles of Incorporation or Bylaws
12:00am